Infleqtion and Churchill Capital Corp X Announce Filing of Registration Statement on Form S-4 in Connection with Proposed Business Combination

BOULDER, Colo. & NEW YORK–(BUSINESS WIRE)–Infleqtion, a global leader in neutral-atom–based quantum technology, and Churchill Capital Corp X (NASDAQ: CCCX), a publicly traded special purpose acquisition company, today announced the filing with the U.S. Securities and Exchange Commission of their joint registration statement on Form S-4 (the “Registration Statement”) in connection with their proposed business combination. The Registration Statement includes a preliminary proxy statement/prospe
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks